非对映体
化学
高效液相色谱法
蛋白酶
立体化学
人类免疫缺陷病毒(HIV)
催化加氢
HIV-1蛋白酶
硝基
蛋白酶抑制剂(药理学)
催化作用
色谱法
酶
有机化学
抗逆转录病毒疗法
病毒载量
医学
家庭医学
烷基
作者
Yoko Yuasa,Y. YUASA,Haruki Tsuruta
标识
DOI:10.1080/00397919808005092
摘要
Abstract (S)-3-tert-Butoxycarbonylamino-1-nitro-2-oxo-4-phenylbutan 4 was converted to (2R, 3S)-1-amino-3-tert-butoxycarbonylamino-2-hydroxy-4-phenylbutane 5a by a catalytic hydrogenation, or NaBH4-TiCl4 reduction followed by hydrogenation in favorable diastereoselectivity, a component of the HIV protease inhibitor VX-478. Notes The HPLC chromatogram showed two signals with tr = 9.9 and 10.6 min assignable to the (2R,3S) and (2S,3S)-diastereomer, respectively. The HPLC chromatogram showed two signals with tr = 13.9 and 15.1 min assignable to the (2S,3S)- and (2R,3S)-diastereomer, respectively.
科研通智能强力驱动
Strongly Powered by AbleSci AI